1. Adler V, Yin Z, Fuchs SY, Benerza M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ and Ronai Z . (1999). EMBO J., 18, 1321–1334.
2. Baez S, Segura-Aguilar J, Widersten M, Johansson AS and Mannervik B . (1997). Biochem. J., 324 (Part 1), 25–28.
3. Bakker J, Lin X and Nelson WG . (2002). J. Biol. Chem., 277, 22573–22580.
4. Black SM, Beggs JD, Hayes JD, Bartoszek A, Muramatsu M, Sakai M and Wolf CR . (1990). Biochem. J., 268, 309–315.
5. Brown GL, Lum RT, Schow SR, Maack C, Vollmer C, Gomez R, Delioukina M, Boulos L, Laxa B, Brown J and Rosen LS . (2001). TLK286: phase I dose escalation trial in patients with advanced malignancies.